AstraZeneca, J&J share new data in bids to expand reach of lung cancer drugs

CHICA­GO — This week­end, As­traZeneca can­cer R&D chief Su­san Gal­braith is wear­ing a lapel pin with the num­ber six, mark­ing the years As­traZeneca has …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.